3 The trials main goal of showing that CagriSema was at least as effective as Mounjaro wasnt met
As part of the Semaglutide Unabated Sustainability in Treatment of Type 2 Diabetes (SUSTAIN) program, the efficacy of once-weekly subcutaneous semaglutide was evaluated in over 7,000 patients in six global phase IIIa trials (SUSTAIN 16) across the wide spectrum of the T2D disease course ( Table 1 )
This ongoing support helps prevent weight regain and keeps you feeling your best
By integrating insights from redox biology and nanotechnology, this review offers a timely and original perspective on the opportunities and challenges of exploiting tumor redox imbalance for precision drug delivery and cancer therapy
Thus, caution is warranted in interpreting these findings as guidance for clinical practices.
(1) (2) (3) (4) (5) (6) Eric Verdin, Euan Ashley, Joseph C